Signe Risum

The diagnostic value of PET/CT for primary ovarian cancer—A prospective study

Signe Risum, Annika Loft, Anne Kiil Berthelsen et al. · Gynecologic Oncology · 2007 · 173 citations

Medicine, Oncology, Radiology +16

High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial

Bjørn Henning Grønberg, Kristin Toftaker Killingberg, Øystein Fløtten et al. · The Lancet Oncology · 2021 · 138 citations · Full text

Medicine, Oncology, Radiation Oncology +11

Neo-AEGIS (Neoadjuvant trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study): Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy (Modified MAGIC or FLOT protocol). (NCT01726452).

John V. Reynolds, Shaun R. Preston, Brian O’Neill et al. · Journal of Clinical Oncology · 2021 · 115 citations

Medicine, Oncology, Radiation Oncology +17

Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography—A prospective study

Signe Risum, Claus Høgdall, Annika Loft et al. · Gynecologic Oncology · 2007 · 105 citations

Medicine, Gynecology, Oncology +16

Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer?

Signe Risum, Claus Høgdall, Annika Loft et al. · Gynecologic Oncology · 2009 · 73 citations

Medicine, Oncology, Radiology +14